RxDoctor Payments Data

Joseph Fischer

Optometrist · Gillette, WYNPI 1154639201

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Alcon at 56.0% of the total. Reporting peaked in 2023 at $263 and has fallen 68.1% since, to $84 in 2025.

$918in general payments, 2019–2025

Across 41 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$514
  • LKC Technologies, Inc.$120
  • Bausch & Lomb Americas Inc.$76
  • Carl Zeiss Meditec, Inc.$49
  • Coopervision Inc.$46
  • AbbVie$36
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$918100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$918 in reported general payments places this provider in the 80th percentile of 102 optometrist providers in Wyoming.

See all optometrist providers in Wyoming

Medicare billing

Part B allowed, 2024
$69,976
Medicare patients
329
Services billed
666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate44$1,129
Latanoprost46$412
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha16$243
Timolol Maleate12$33

Paid to pharmacies, not to this prescriber.

Other optometrist in Gillette

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →